Sign in
4

Changes in Ownership

ATOSSA THERAPEUTICS, INC. Filed Acc 0001566618-14-000003

Options or other derivatives

  • CFO & General Counsel acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Guse Kyle CFO & General Counsel 2014-05-06 Grant or award · Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X03/primary_doc.xml…